The high-risk E6 oncoprotein has been shown to degrade p53, resulting in the inhibition of apoptosis, which is a key step to progress to cervical cancer (Howie et al., 2009; Kajitani et al., 2012; Zheng et al., 2020). Here, TP53 is linked to cervical carcinoma.